Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Bibliographic Details
Title: Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Authors: Leonie Stolz, Amin Derouiche, Kavi Devraj, Frank Weber, Robert Brunkhorst, Christian Foerch
Source: Journal of Neuroinflammation, Vol 14, Iss 1, Pp 1-10 (2017)
Publisher Information: BMC, 2017.
Publication Year: 2017
Collection: LCC:Neurology. Diseases of the nervous system
Subject Terms: Multiple sclerosis, Experimental autoimmune encephalomyelitis, Inflammation, Mice, Anticoagulation, Neurology. Diseases of the nervous system, RC346-429
More Details: Abstract Background In multiple sclerosis, coagulation factors have been shown to modulate inflammation. In this translational study, we investigated whether long-term anticoagulation with warfarin or rivaroxaban has beneficial effects on the course of autoimmune experimental encephalomyelitis (EAE). Methods Female SJL/J mice treated with anticoagulants namely warfarin or rivaroxaban were immunized with PLP139–151. Stable anticoagulation was maintained throughout the entire experiment. Mice without anticoagulation treated with the vehicle only were used as controls. The neurological deficit was recorded during the course of EAE, and histopathological analyses of inflammatory lesions were performed. Results In preventive settings, both treatment with warfarin and rivaroxaban reduced the maximum EAE score as compared to the control group and led to a reduction of inflammatory lesions in the spinal cord. In contrast, therapeutic treatment with warfarin had no beneficial effects on the clinical course of EAE. Signs of intraparenchymal hemorrhage at the site of the inflammatory lesions were not observed. Conclusion We developed long-term anticoagulation models that allowed exploring the course of EAE under warfarin and rivaroxaban treatment. We found a mild preventive effect of both warfarin and rivaroxaban on neurological deficits and local inflammation, indicating a modulation of the disease induction by anticoagulation.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1742-2094
Relation: http://link.springer.com/article/10.1186/s12974-017-0926-2; https://doaj.org/toc/1742-2094
DOI: 10.1186/s12974-017-0926-2
Access URL: https://doaj.org/article/a648f7d0e5f8459493dbf5ba38b51b7d
Accession Number: edsdoj.648f7d0e5f8459493dbf5ba38b51b7d
Database: Directory of Open Access Journals
More Details
ISSN:17422094
DOI:10.1186/s12974-017-0926-2
Published in:Journal of Neuroinflammation
Language:English